![](https://monteverdelaw.com/wp-content/uploads/case-logo/reunion-neuroscience-inc.jpg)
Reunion Neuroscience Inc. (NASDAQ: REUN), relating to its proposed sale to affiliates of MPM BioImpact. Under the terms of the agreement, REUN shareholders will receive $1.12 in cash per share they own.
Reunion Neuroscience Inc. (NASDAQ: REUN), relating to its proposed sale to affiliates of MPM BioImpact. Under the terms of the agreement, REUN shareholders will receive $1.12 in cash per share they own.